Literature DB >> 29656309

Serious adverse drug reactions with sacubitril/valsartan Entresto®: a French pharmacovigilance survey.

Florence Moulis1, Vanessa Rousseau1, Leila Chebane1, Amandine Gouverneur2, Louise Gaboriau3, Jean-Luc Faillie4,5, Geneviève Durrieu1, François Montastruc1, Jean-Louis Montastruc6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29656309     DOI： 10.1007/s00228-018-2460-2

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  4 in total

1.  Causality assessment in pharmacovigilance: The French method and its successive updates.

Authors:  Ghada Miremont-Salamé; Hélène Théophile; Françoise Haramburu; Bernard Bégaud
Journal:  Therapie       Date:  2016-02-06       Impact factor: 2.070

2.  French pharmacovigilance: Missions, organization and perspectives.

Authors:  Thierry Vial
Journal:  Therapie       Date:  2016-02-20       Impact factor: 2.070

3.  Angiotensin-neprilysin inhibition versus enalapril in heart failure.

Authors:  John J V McMurray; Milton Packer; Akshay S Desai; Jianjian Gong; Martin P Lefkowitz; Adel R Rizkala; Jean L Rouleau; Victor C Shi; Scott D Solomon; Karl Swedberg; Michael R Zile
Journal:  N Engl J Med       Date:  2014-08-30       Impact factor: 91.245

Review 4.  Is Entresto good for the brain?

Authors:  Nirav Patel; Jason Gluck
Journal:  World J Cardiol       Date:  2017-07-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.